DURHAM, N.C. – The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke ...
DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...
When a traumatic injury occurs to an artery, if a patient’s own veins aren't available for use as a bypass graft, they’ll typically have to be treated either with a synthetic implant or with surgical ...
A new research paper was published in Aging, titled "Reduction of double-strand DNA break repair exacerbates vascular aging." Advanced age is the greatest risk factor for cardiovascular disease (CVD), ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth announced today that it performed its first vascular surgical procedure for aneurysm repair utilizing advanced AI technology. Allan Conway, MD, Clinical ...
For applications beyond extremity vascular trauma, Symvess remains investigational and has not received regulatory approval. In other recent news, Humacyte has announced plans to file a Marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results